Related Experiment Videos
Hormonal changes associated with induced late abortions in the mare
1Department of Obstetrics and Gynaecology, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Summary
Prostaglandin F-2 alpha (PGF-2 alpha) and oxytocin treatments effectively induced abortion in mares. Oxytocin caused more uterine activity and potential uterine damage compared to PGF-2 alpha.
Area of Science:
- Veterinary Medicine
- Reproductive Biology
- Endocrinology
Background:
- Pregnancy termination in mares can be achieved through hormonal interventions.
- Understanding the physiological responses to different abortifacient agents is crucial for reproductive management.
Purpose of the Study:
- To compare the efficacy and physiological effects of prostaglandin F-2 alpha (PGF-2 alpha) and a combination of oestradiol benzoate and oxytocin for inducing abortion in mares at approximately 150 days of gestation.
Main Methods:
- Two pregnant mares were treated with PGF-2 alpha twice daily until abortion.
- Two pregnant mares received a combined treatment of oestradiol benzoate and oxytocin.
- Hormonal concentrations (15-ketodihydro-PGF-2 alpha, progesterone, relaxin, oestrone sulphate, PMSG) were monitored before and after treatment and abortion.
Main Results:
- Both treatments induced abortion, with PGF-2 alpha treated mares aborting between 37-61 hours and oxytocin-treated mares between 13-27 hours.
- Oxytocin treatment resulted in stronger uterine contractions and disrupted fetal membranes, suggesting potential uterine damage, indicated by a large increase in 15-ketodihydro-PGF-2 alpha.
- PGF-2 alpha treatment led to an immediate return to basal 15-ketodihydro-PGF-2 alpha levels post-abortion.
- Oestrone sulphate levels decreased rapidly after oxytocin but showed an initial increase followed by a decrease after PGF-2 alpha.
- Progesterone and relaxin decreased in both groups, reflecting placental function decline.
Conclusions:
- Both PGF-2 alpha and oxytocin can induce abortion in mares, but oxytocin appears to be faster acting and associated with more intense uterine activity.
- Hormonal profiles differ between the two treatments, with oxytocin potentially causing more significant uterine trauma.